PCV33 A COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN FOUR EUROPEAN COUNTRIES
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67445-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)67445-1/fulltext
Title :
PCV33 A COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN FOUR EUROPEAN COUNTRIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67445-1&doi=10.1016/S1098-3015(10)67445-1
First page :
Section Title :
Open access? :
No
Section Order :
690